New Study Finds Coffee — including decaf — Changes Gut Microbes and May Affect Mood, Stress and Memory
New APC Microbiome Ireland research published in Nature Communications shows that both caffeinated and decaffeinated coffee significantly shift gut microbes, with changes linked to improved mood, lower stress, and specific gains in cognition via the gut-brain axis.
Key takeaways
- APC Microbiome Ireland study published in Nature Communications reports gut and metabolite shifts after coffee use.
- Both caffeinated and decaf shifted gut metabolite profiles and increased bacteria linked to digestion and inflammation control.
- Habitual drinkers (3–5 cups/day) reported lower perceived stress and depression; caffeinated coffee tied to reduced anxiety and improved attention, decaf to better learning and episodic memory.
- Study limits: modest sample (62 adults), self-reported diaries, incomplete control of coffee additives; funding included the Institute for Scientific Information on Coffee (ISIC).
Study design and methods
The trial followed 62 adults — 31 habitual coffee drinkers (reporting three to five cups daily) and 31 non-drinkers. The habitual range is described as moderate and aligns with European Food Safety Authority guidance. The protocol combined psychological testing, diet and caffeine diaries, and biological sampling: stool and urine were analyzed for microbial and metabolic changes.
Participants observed a two-week coffee abstinence period, then habitual drinkers were blindly reintroduced to either caffeinated or decaffeinated coffee. Researchers compared microbial taxa, metabolite shifts, and cognitive and mood measures before and after reintroduction. Details and study summary are available from the University College Cork research summary and a News‑Medical write-up.
Which microbes changed and why it matters
Researchers observed higher levels of specific bacteria in coffee consumers. Two named taxa were Eggerthella and Cryptobacterium curtum. Eggerthella is associated with gastric and intestinal acid secretion, while Cryptobacterium curtum participates in bile-acid–related processes that help clear harmful microbes and modulate inflammation.
The team also reported shifts in Firmicutes, a broad group previously linked in some studies to positive emotion measures, particularly in women. Those microbial changes corresponded to altered metabolite profiles — small chemicals produced by microbes — which can influence systems beyond the gut.
Gut-brain axis benefits: mood, stress and cognition
The work strengthens evidence that the gut-brain axis — the bidirectional communication between gut microbes, their metabolites, and brain function — is a pathway through which coffee may affect mental health. Both caffeinated and decaf drinkers reported lower perceived stress, fewer depression symptoms, and reduced impulsivity.
The study highlighted beverage-specific patterns: caffeinated coffee was associated with reduced anxiety and sharper attention and vigilance; decaf linked to improved learning and episodic memory, possibly through better sleep and daytime activity among decaf users.
“Coffee is more than just caffeine — it’s a complex dietary factor that interacts with our gut microbes, our metabolism, and even our emotional wellbeing.” — Professor John Cryan, APC Microbiome Ireland
What compounds may be doing the work
Lead investigators emphasized non‑caffeine compounds such as polyphenols and antioxidants. These molecules can selectively feed or inhibit certain microbes, shifting the mix of microbial metabolites (including bile acids and inflammatory mediators) that in turn affect neurochemistry and physiology.
The authors note that coffee likely operates through multiple routes: direct chemical effects, microbial metabolism, and downstream inflammation and neurochemical changes that together shape mood and cognition.
Limitations and cautions
The researchers were explicit about the study’s limits: reliance on self-reported diet and mood scales (vulnerable to recall and subjective bias), modest sample size (62 participants), and incomplete control for coffee additives (sugar, cream, milk, flavorings) that can independently alter gut microbes. The trial was not designed to demonstrate long-term causality.
The work was sponsored in part by the Institute for Scientific Information on Coffee (ISIC), which the authors disclosed. The presence of industry support is important context but does not by itself invalidate the findings.
How this fits with other evidence
Prior observational and shorter-term studies have linked coffee to lower risks of certain chronic conditions and to transient mood effects. This trial adds mechanistic links between coffee, the gut microbiome, and specific metabolite changes that may help explain earlier associations. The inclusion of a decaf arm strengthens the case that non‑caffeine components of coffee matter.
Still, the authors call for larger, longer, and independently funded trials to confirm benefits and to disentangle coffee effects from lifestyle and dietary confounders.
Implications for the United States
- Personal decisions: For many Americans, coffee may be a modest component of gut-health and mental-wellbeing strategies; decaf could offer benefits for those sensitive to caffeine.
- Healthcare guidance: Clinicians may discuss moderation and preparation choices (limit added sugars and high‑fat creamers) and reference the European Food Safety Authority moderate range reflected in this study (three to five cups/day).
- Public health messaging: Agencies should emphasize that coffee may contribute to well‑being but is not a substitute for balanced diet, exercise, or evidence-based mental health care.
- Industry and regulation: Transparency about funding (e.g., ISIC sponsorship) matters; policymakers and reviewers may call for more independent research before changing guidelines.
- Practical tips: Consider decaf in the evening to protect sleep, reduce sugar and high‑calorie additives, and view coffee as one part of an overall healthy lifestyle.
Reporting notes and sources
This story is based on material from APC Microbiome Ireland and reporting on the Nature Communications paper. Key sources include the University College Cork research summary, a News‑Medical report, and broader coverage at Ground.News.
Reporting continues with follow-up and requests for comment to APC Microbiome Ireland and the Institute for Scientific Information on Coffee.
